But outcome trials needed!
More than 30 million Americans take statins to lower their cholesterol, according to estimates. But these popular drugs don't work for everyone. Now the FDA may be poised to approve a powerful new class of drugs that can attack cholesterol levels in a different way. Hari Sreenivasan talks to Dr. Steven Nissen of the Cleveland Clinic and Dr. Harlan Krumholz of the Yale School of Medicine.
Add a comment...